Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
Cancer|April 16, 2013
Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilonesDana M Roque, Stefania Bellone, Diana P English, et al.
Journal of Virology|April 24, 2009
Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccinesStefania Bellone, Karim El-Sahwi, Emiliano Cocco, et al.
Gynecologic Oncology|May 2, 2015
Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patientsStefania Bellone, Floriana Centritto, Jonathan Black, et al.
Frontiers in Oncology|February 7, 2019
Human Ovarian Cancer Tumor Formation in Severe Combined Immunodeficient (SCID) PigsAdeline N Boettcher, Matti Kiupel, Malavika K Adur, et al.
Gynecologic Oncology|August 7, 2026
Integrated expression profiling of trophoblast cell-surface antigen 2 (TROP2), folate receptor alpha (FRα), and human epidermal growth factor receptor 2 (HER2) in endometrial Cancer across molecular classes, genomic alterations, and histologic subtypesOrazio De Tommasi, Luca Palmieri, Stefania Bellone, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 14, 2012
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomasFederica Guzzo, Stefania Bellone, Natalia Buza, et al.
Cancer|June 22, 2011
Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxinFrancesca Casagrande, Emiliano Cocco, Stefania Bellone, et al.
American Journal of Obstetrics and Gynecology|August 15, 2015
Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitroStefania Bellone, Jonathan Black, Diana P English, et al.
International Journal of Cancer|August 12, 2004
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapyAlessandro D Santin, Fenghuang Zhan, Stefania Bellone, et al.
Gynecologic Oncology|February 14, 2026
Remarkable preclinical activity of trastuzumab-deruxtecan (T-DXd) in FISH-negative, HER2 IHC 1+ and 2+ expressing primary endometrial cancer cell lines and xenograftsLuca Palmieri, Stefania Bellone, Cem Demirkiran, et al.
Pageof 17